The acquisition of IMS Health by TPG Capital and the CPP Investment Board passed its last final hurdle today. IMS stockholders approved the sale in a vote earlier today. Last week, IMS got the green light from European regulators for the buyout.
However, IMS may have one more unforeseen hurdle. The company is trying to float $1 billion in high-yield junk bonds to cough up enough money for its side of the transaction. However, just as IMS is trying to float the bonds, the market for junk debt is softening.